LACERTA THERAPEUTICS

Serial Number 97077194
606

Registration Progress

Application Filed
Oct 15, 2021
Under Examination
Oct 18, 2022
Approved for Publication
Aug 23, 2022
Published for Opposition
Aug 23, 2022
Registered

Basic Information

Serial Number
97077194
Filing Date
October 15, 2021
Published for Opposition
August 23, 2022
Abandonment Date
November 20, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 20, 2023
Classes
042

Rights Holder

Lacerta Therapeutics, Inc.

03
Address
14189 NW 129th Way
Alachua, FL 32615

Ownership History

Lacerta Therapeutics, Inc.

Original Applicant
03
Alachua, FL

Lacerta Therapeutics, Inc.

Owner at Publication
03
Alachua, FL

Legal Representation

Attorney
Maxwell Minch

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

20 events
Date Code Type Description
Nov 20, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Nov 20, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 14, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 13, 2023 EX1G S SOU EXTENSION 1 GRANTED
Jul 10, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 26, 2023 NREV E NOTICE OF REVIVAL - E-MAILED
May 25, 2023 PROA I TEAS PETITION TO REVIVE RECEIVED
May 25, 2023 PETG O PETITION TO REVIVE-GRANTED
May 25, 2023 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION
May 22, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
May 22, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 18, 2023 EXT1 S SOU EXTENSION 1 FILED
Oct 18, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 23, 2022 PUBO A PUBLISHED FOR OPPOSITION
Aug 23, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 3, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 21, 2022 DOCK D ASSIGNED TO EXAMINER
Jul 21, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 19, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Gene therapy, namely, research and development services in the field of gene therapy
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"